| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.
|
AIDS
|
2006
|
7.99
|
|
2
|
Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.
|
Int J Radiat Oncol Biol Phys
|
2009
|
4.23
|
|
3
|
Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.
|
J Acquir Immune Defic Syndr
|
2010
|
4.20
|
|
4
|
Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.
|
Curr HIV/AIDS Rep
|
2010
|
3.80
|
|
5
|
Pancreaticoduodenectomy: a 20-year experience in 516 patients.
|
Arch Surg
|
2004
|
2.29
|
|
6
|
Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya.
|
Bull World Health Organ
|
2010
|
2.21
|
|
7
|
The OpenMRS Implementers Network.
|
Int J Med Inform
|
2009
|
2.19
|
|
8
|
Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.
|
Clin Infect Dis
|
2004
|
2.17
|
|
9
|
Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America.
|
PLoS Med
|
2011
|
2.17
|
|
10
|
Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.
|
J Acquir Immune Defic Syndr
|
2013
|
2.15
|
|
11
|
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
|
Ann Surg
|
2007
|
2.10
|
|
12
|
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
|
AIDS
|
2007
|
2.09
|
|
13
|
Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.
|
J Neurovirol
|
2010
|
1.95
|
|
14
|
Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya.
|
J Acquir Immune Defic Syndr
|
2006
|
1.87
|
|
15
|
Outcomes of HIV-exposed children in western Kenya: efficacy of prevention of mother to child transmission in a resource-constrained setting.
|
J Acquir Immune Defic Syndr
|
2010
|
1.86
|
|
16
|
Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa.
|
Trop Med Int Health
|
2010
|
1.75
|
|
17
|
Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels.
|
AIDS
|
2002
|
1.68
|
|
18
|
Ordered multiple-class ROC analysis with continuous measurements.
|
Stat Med
|
2004
|
1.65
|
|
19
|
Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach.
|
PLoS One
|
2011
|
1.65
|
|
20
|
Clinical validation of the NeuroScreen.
|
J Neurovirol
|
2005
|
1.57
|
|
21
|
The need for double-sampling designs in survival studies: an application to monitor PEPFAR.
|
Biometrics
|
2008
|
1.50
|
|
22
|
Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection.
|
J Acquir Immune Defic Syndr
|
2008
|
1.46
|
|
23
|
The impact of the President's Emergency Plan for AIDS Relief on expansion of HIV care services for adult patients in western Kenya.
|
AIDS
|
2009
|
1.44
|
|
24
|
Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity.
|
J Neuropsychiatry Clin Neurosci
|
2007
|
1.39
|
|
25
|
Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study.
|
Leuk Res
|
2004
|
1.39
|
|
26
|
Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?
|
J Int AIDS Soc
|
2011
|
1.36
|
|
27
|
A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis.
|
J Magn Reson Imaging
|
2003
|
1.34
|
|
28
|
Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.
|
J Neurovirol
|
2011
|
1.31
|
|
29
|
Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya.
|
Trop Med Int Health
|
2010
|
1.31
|
|
30
|
A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.29
|
|
31
|
Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV.
|
J Int Neuropsychol Soc
|
2008
|
1.26
|
|
32
|
Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.
|
J Acquir Immune Defic Syndr
|
2010
|
1.25
|
|
33
|
A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa.
|
Am J Epidemiol
|
2012
|
1.24
|
|
34
|
Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
|
J Int AIDS Soc
|
2011
|
1.24
|
|
35
|
Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
|
J Neurovirol
|
2010
|
1.22
|
|
36
|
Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort.
|
J Acquir Immune Defic Syndr
|
2013
|
1.21
|
|
37
|
Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda.
|
J Acquir Immune Defic Syndr
|
2011
|
1.21
|
|
38
|
Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.
|
Arch Surg
|
2003
|
1.17
|
|
39
|
Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.
|
AIDS
|
2014
|
1.12
|
|
40
|
Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment.
|
Neuroimage Clin
|
2013
|
1.01
|
|
41
|
Pancreatic fistula following pancreaticoduodenectomy: clinical predictors and patient outcomes.
|
HPB Surg
|
2009
|
0.98
|
|
42
|
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy.
|
J Neuroinflammation
|
2013
|
0.95
|
|
43
|
Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.
|
PLoS One
|
2013
|
0.95
|
|
44
|
Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy.
|
HPB (Oxford)
|
2010
|
0.92
|
|
45
|
Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regional analysis.
|
Pediatr Infect Dis J
|
2014
|
0.92
|
|
46
|
Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study.
|
Am J Med Genet B Neuropsychiatr Genet
|
2003
|
0.92
|
|
47
|
Modulation of in vitro proliferation kinetics and primitive hematopoietic potential of individual human CD34+CD38-/lo cells in G0.
|
Blood
|
2004
|
0.91
|
|
48
|
Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: A Hoosier Oncology Group Trial, HEM01-21.
|
Oncologist
|
2007
|
0.89
|
|
49
|
Innovative approaches to application of information technology in disease surveillance and prevention in Western Kenya.
|
J Biomed Inform
|
2006
|
0.88
|
|
50
|
Cardiac related death in thalassaemia major: time trend and risk factors in a large Greek Unit.
|
Eur J Haematol
|
2009
|
0.88
|
|
51
|
A comparison of tests for restricted orderings in the three-class case.
|
Stat Med
|
2009
|
0.87
|
|
52
|
Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations.
|
J Acquir Immune Defic Syndr
|
2014
|
0.87
|
|
53
|
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.
|
J Neurovirol
|
2006
|
0.86
|
|
54
|
Accuracy and cut-off point selection in three-class classification problems using a generalization of the Youden index.
|
Stat Med
|
2010
|
0.86
|
|
55
|
A sequential design to estimate sensitivity and specificity of a diagnostic or screening test.
|
Stat Med
|
2006
|
0.85
|
|
56
|
Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
|
J Am Coll Surg
|
2011
|
0.82
|
|
57
|
Untangling the Relationship Between Antiretroviral Therapy Use and Incident Pregnancy: A Marginal Structural Model Analysis Using Data From 47,313 HIV-Positive Women in East Africa.
|
J Acquir Immune Defic Syndr
|
2016
|
0.80
|
|
58
|
Assessment of diagnostic markers by goodness-of-fit tests.
|
Stat Med
|
2003
|
0.80
|
|
59
|
Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.
|
J Acquir Immune Defic Syndr
|
2016
|
0.79
|
|
60
|
Longitudinal characterization of depression and mood states beginning in primary HIV infection.
|
AIDS Behav
|
2014
|
0.78
|
|
61
|
Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings.
|
J Acquir Immune Defic Syndr
|
2015
|
0.78
|
|
62
|
CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa.
|
Int J Epidemiol
|
2015
|
0.76
|
|
63
|
Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
|
AIDS
|
2016
|
0.76
|
|
64
|
Choosing profile double-sampling designs for survival estimation with application to President's Emergency Plan for AIDS Relief evaluation.
|
Stat Med
|
2014
|
0.75
|
|
65
|
All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.
|
AIDS
|
2017
|
0.75
|
|
66
|
Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
|
Gynecol Oncol
|
2005
|
0.75
|
|
67
|
A multi-index ROC-based methodology for high throughput experiments in gene discovery.
|
Int J Data Min Bioinform
|
2013
|
0.75
|
|
68
|
An Observational Study of the Effect of Patient Outreach on Return to Care: The Earlier the Better.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
69
|
Phase II design with sequential testing of hypotheses within each stage.
|
J Biopharm Stat
|
2014
|
0.75
|